Skip to content
HowShorted

Anika Therapeutics Inc. short interest in 2024

In 2024, Anika Therapeutics Inc.'s disclosed short interest ran from 3.56% of shares outstanding on 12 Jan 2024 to 2.66% on 31 Dec 2024, a change of -0.90 percentage points. The year's high was 5.54% on 15 Apr 2024 and its low 2.51% on 29 Nov 2024, averaging 4.25% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.78 days on 13 Sep 2024. Full history: Anika Therapeutics Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Anika Therapeutics Inc. in 2024

2024 in figures

Start of year
3.56% (12 Jan 2024)
End of year
2.66% (31 Dec 2024)
Change
-0.90 pp
High
5.54% (15 Apr 2024)
Low
2.51% (29 Nov 2024)
Average
4.25%
Highest days to cover
19.78 (13 Sep 2024)
SEC filings marked
8

Every report in 2024

Anika Therapeutics Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20243.56%7.14
31 Jan 20243.61%6.81
15 Feb 20243.91%10.51
29 Feb 20243.95%5.63
15 Mar 20245.23%6.60results (8-K), 10-K filed
28 Mar 20245.26%8.75
15 Apr 20245.54%12.28
30 Apr 20245.45%17.30
15 May 20245.32%10.7210-Q filed, results (8-K)
31 May 20245.02%15.42
14 Jun 20244.95%17.18
28 Jun 20244.94%10.07
15 Jul 20244.80%18.11
31 Jul 20244.52%15.39
15 Aug 20244.56%14.9110-Q filed, results (8-K)
30 Aug 20244.57%15.53
13 Sep 20244.55%19.78
30 Sep 20244.32%8.57
15 Oct 20243.31%9.37
31 Oct 20243.31%6.50results (8-K)
15 Nov 20243.47%2.8810-Q filed
29 Nov 20242.51%3.44
13 Dec 20242.60%4.50
31 Dec 20242.66%4.74

See also: Anika Therapeutics Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.